Ready-to-Use IV Products


April 2013 : State of Pharmacy Compounding - Vol. 10 No. 4 - Page #41

The safety of ready-to-use products, manufactured under FDA cGMP requirements, delivers peace of mind to pharmacy. In addition, their added convenience ensures the continuing popularity of these products: 91% of all facilities are taking advantage of at least some RTUs to meet their IV delivery needs. Most facilities (66%) choose a combination of piggyback and syringe systems, just 6% of facilities use a syringe system only. RTU products generally supplement compounded formulations, however, 32% of all facilities are purchasing greater than 50% of their IVs as RTU.

To view the PDF, click the download link above.


Download SOPC 2013 Powerpoint SlidesSelect graphs from the State of Pharmacy Compounding are available for your use as PowerPoint slides. Click here to download

Login

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: